103 related articles for article (PubMed ID: 8314962)
1. The effects of a gonadotrophin-releasing hormone agonist on treatment with low dose follicle stimulating hormone in polycystic ovary syndrome.
Scheele F; Hompes PG; van der Meer M; Schoute E; Schoemaker J
Hum Reprod; 1993 May; 8(5):699-704. PubMed ID: 8314962
[TBL] [Abstract][Full Text] [Related]
2. The relationship between follicle-stimulating hormone dose and level and its relevance for ovulation induction with adjuvant gonadotropin-releasing hormone-agonist treatment.
Scheele F; Hompes PG; van der Meer M; Schoute E; Schoemaker J
Fertil Steril; 1993 Oct; 60(4):620-5. PubMed ID: 8405514
[TBL] [Abstract][Full Text] [Related]
3. Polycystic ovary syndrome: low-dose follicle stimulating hormone administration is a safe stimulation regimen even in previous hyper-responsive patients.
Dale PO; Tanbo T; Haug E; Abyholm T
Hum Reprod; 1992 Sep; 7(8):1085-9. PubMed ID: 1400931
[TBL] [Abstract][Full Text] [Related]
4. The step-down principle in gonadotrophin treatment and the role of GnRH analogues.
Fauser BC; Donderwinkel P; Schoot DC
Baillieres Clin Obstet Gynaecol; 1993 Jun; 7(2):309-30. PubMed ID: 8358893
[TBL] [Abstract][Full Text] [Related]
5. Growth of the dominant follicle is similar to normal in patients with gonadotrophin-stimulated polycystic ovary syndrome exhibiting monofollicular development during a decremental dose regimen.
Schoot DC; Hop WC; Pache TD; de Jong FH; Fauser BC
Acta Endocrinol (Copenh); 1993 Aug; 129(2):126-9. PubMed ID: 8372596
[TBL] [Abstract][Full Text] [Related]
6. Low-dose follicle stimulating hormone for ovulation induction in polycystic ovary syndrome.
Strowitzki T; Seehaus D; Korell M; Hepp H
J Reprod Med; 1994 Jul; 39(7):499-503. PubMed ID: 7966037
[TBL] [Abstract][Full Text] [Related]
7. The importance of endogenous feedback for monofollicular growth in low-dose step-up ovulation induction with follicle-stimulating hormone in polycystic ovary syndrome: a randomized study.
van der Meer M; Hompes PG; Scheele F; Schoute E; Popp-Snijders C; Schoemaker J
Fertil Steril; 1996 Oct; 66(4):571-6. PubMed ID: 8816618
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of basal luteinizing hormone:follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques.
Tarlatzis BC; Grimbizis G; Pournaropoulos F; Bontis J; Lagos S; Spanos E; Mantalenakis S
Hum Reprod; 1995 Oct; 10(10):2545-9. PubMed ID: 8567767
[TBL] [Abstract][Full Text] [Related]
9. Pulsatile gonadotrophin releasing hormone stimulation after medium-term pituitary suppression in polycystic ovary syndrome.
Scheele F; Hompes PG; van der Meer M; Schoute E; Schoemaker J
Hum Reprod; 1993 Nov; 8 Suppl 2():197-9. PubMed ID: 8276960
[TBL] [Abstract][Full Text] [Related]
10. Follicle stimulating hormone (FSH) dynamics of low dose step-up ovulation induction with FSH in patients with polycystic ovary syndrome.
van der Meer M; Hompes PG; Scheele F; Schoute E; Veersema S; Schoemaker J
Hum Reprod; 1994 Sep; 9(9):1612-7. PubMed ID: 7836509
[TBL] [Abstract][Full Text] [Related]
11. The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome.
Dale PO; Tanbo T; Haug E; Abyholm T
Hum Reprod; 1998 Mar; 13(3):567-70. PubMed ID: 9572412
[TBL] [Abstract][Full Text] [Related]
12. Octreotide, a somatostatin analogue, alters ovarian sensitivity to gonadotrophin stimulation as measured by the follicle stimulating hormone threshold in polycystic ovary syndrome.
van der Meer M; de Boer JA; Hompes PG; Schoemaker J
Hum Reprod; 1998 Jun; 13(6):1465-9. PubMed ID: 9688372
[TBL] [Abstract][Full Text] [Related]
13. Ovulation induction with low doses of "pure" follicle stimulating hormone using a fixed protocol in patients with polycystic ovarian disease.
Bregieiro LO; de Moura MD; Ferriani RA; Bailão LA; de Sá MF
Int J Fertil Menopausal Stud; 1993; 38(3):152-9. PubMed ID: 8348163
[TBL] [Abstract][Full Text] [Related]
14. The effects of gonadotrophin-releasing hormone agonist on follicular development in patients with polycystic ovary syndrome in an in-vitro fertilization and embryo transfer programme.
Gersak K; Meden-Vrtovec H; Tomazevic T
Hum Reprod; 1994 Sep; 9(9):1596-9. PubMed ID: 7836506
[TBL] [Abstract][Full Text] [Related]
15. The effect of low dose human chorionic gonadotropin on follicular response and oocyte maturation in PCOS patients undergoing IVF cycles: a randomized clinical trial of efficacy and safety.
Ashrafi M; Kiani K; Ghasemi A; Rastegar F; Nabavi M
Arch Gynecol Obstet; 2011 Dec; 284(6):1431-8. PubMed ID: 21210134
[TBL] [Abstract][Full Text] [Related]
16. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.
Nugent D; Vandekerckhove P; Hughes E; Arnot M; Lilford R
Cochrane Database Syst Rev; 2000; (4):CD000410. PubMed ID: 11034687
[TBL] [Abstract][Full Text] [Related]
17. Exploring the recovery phase after treatment with a gonadotrophin-releasing hormone-agonist for ovulation induction in polycystic ovary syndrome: three pilot trials.
Scheele F; van der Meer M; Lambalk CB; Schoute E; Schoemaker J; Hompes PG
Eur J Obstet Gynecol Reprod Biol; 1995 Oct; 62(2):221-4. PubMed ID: 8582500
[TBL] [Abstract][Full Text] [Related]
18. Administration of pure follicle-stimulating hormone during gonadotropin-releasing hormone agonist therapy in patients with clomiphene-resistant polycystic ovarian disease: hormonal evaluations and clinical perspectives.
Remorgida V; Venturini PL; Anserini P; Lanera P; De Cecco L
Am J Obstet Gynecol; 1989 Jan; 160(1):108-13. PubMed ID: 2492145
[TBL] [Abstract][Full Text] [Related]
19. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
Gerris J; De Vits A; Joostens M; Van Royen E
Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071
[TBL] [Abstract][Full Text] [Related]
20. Ovulation of a single dominant follicle during treatment with low-dose pulsatile follicle stimulating hormone in women with polycystic ovary syndrome.
Polson DW; Mason HD; Saldahna MB; Franks S
Clin Endocrinol (Oxf); 1987 Feb; 26(2):205-12. PubMed ID: 3117445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
